Gefitinib 250 mg

Introduction

GEFISTERIS 250 is a high-quality pharmaceutical product that contains Gefitinib (250mg) as its active ingredient. It is primarily used in the treatment of non-small cell lung cancer (NSCLC). As a targeted therapy, GEFISTERIS 250 works by blocking specific proteins that promote the growth of cancer cells, offering a focused and effective approach to cancer care.Manufactured under strict quality standards, GEFISTERIS 250 by Steris Healthcare ensures reliability, safety, and efficacy for patients undergoing long-term cancer treatment.

Key Features and Ingredients

• Active Ingredient: Gefitinib 250mg

• Therapeutic Category: Tyrosine Kinase Inhibitor (TKI)

• Targeted Therapy: Acts specifically on the EGFR (Epidermal Growth Factor Receptor) protein

• Tablet Form: Easy to administer oral formulation

• WHO-GMP Certified: Manufactured in a certified facility ensuring high-quality standards

Usage of GEFISTERIS 250

GEFISTERIS 250 is used for the treatment of:

• Advanced or metastatic non-small cell lung cancer (NSCLC), especially in patients whose tumors have EGFR mutations

• Patients who have not responded to traditional chemotherapy

• Long-term therapy under oncologist supervision

Dosage and Administration:

• One tablet (250mg) daily, with or without food

• Always follow the doctor’s prescription and guidance

• Do not adjust the dose without consulting your healthcare provider

Benefits of GEFISTERIS 250

• Targeted Action: Specifically inhibits the EGFR receptor, minimizing damage to healthy cells

• Improved Quality of Life: Helps in controlling cancer symptoms and slowing disease progression

• Convenient Oral Administration: No need for IV or hospital stays

• Fewer Side Effects compared to traditional chemotherapy

• Proven Efficacy in EGFR-mutated NSCLC patients

FAQs – GEFISTERIS 250 (Gefitinib 250mg)

Q1. What is GEFISTERIS 250 used for?

GEFISTERIS 250 is used in the treatment of non-small cell lung cancer that has specific EGFR gene mutations.

Q2. Is GEFISTERIS 250 a form of chemotherapy?

No, it is a targeted therapy, not a traditional chemotherapy. It works by blocking specific proteins in cancer cells.

Q3. How long can GEFISTERIS 250 be taken?

Duration of treatment depends on the patient’s response and the oncologist’s recommendation. Regular monitoring is essential.

Q4. Are there any common side effects?

Some patients may experience diarrhea, rash, nausea, or dry skin. Always report side effects to your doctor.

Q5. Can GEFISTERIS 250 be taken on an empty stomach?

Yes, it can be taken with or without food, but it should be taken at the same time each day.

Conclusion

GEFISTERIS 250, with its powerful Gefitinib (250mg) composition, is a reliable and effective option for patients battling non-small cell lung cancer. Its targeted mechanism, ease of use, and proven benefits make it a valuable addition to cancer therapy.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW